GSE210200 MI-1 Kasumi-1 SJNB-4 2 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE210200_MI-1_Kasumi-1 SJNB-4_2_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE210200_MI-1_Kasumi-1 SJNB-4_2_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE210200_MI-1_Kasumi-1 SJNB-4_2_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE210200_MI-1_Kasumi-1 SJNB-4_2_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

PRR34 antisense RNA 1

Gene

ITFG2 antisense RNA 1

Gene

uncharacterized LOC105375523

Gene

PRDM6 antisense RNA 1

Gene

H2B.W histone 3, pseudogene

Gene

small integral membrane protein 2

Gene

long intergenic non-protein coding RNA 1360

Gene

RPS3A pseudogene 21

Gene

uncharacterized LOC101929551

Gene

ribosomal protein S27 pseudogene 16

  • Gene

    PRR34 antisense RNA 1


  • Gene

    ITFG2 antisense RNA 1


  • Gene

    uncharacterized LOC105375523


  • Gene

    PRDM6 antisense RNA 1


  • Gene

    H2B.W histone 3, pseudogene


  • Gene

    small integral membrane protein 2


  • Gene

    long intergenic non-protein coding RNA 1360


  • Gene

    RPS3A pseudogene 21


  • Gene

    uncharacterized LOC101929551


  • Gene

    ribosomal protein S27 pseudogene 16

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.